Dye's 1996 theoretical paper asks why biomechanically successful ACL reconstructions still produce degenerative knees. It proposes a conceptual framework — the knee as a biologic transmission with an envelope of function — to explain how load magnitude and frequency interact with tissue homeostasis, and why restoring normal laxity alone is insufficient to restore full joint function.
When a patient has a biomechanically well-reconstructed ACL but develops pain, effusion, or early degenerative changes, think envelope mismatch — the functional capacity of the joint has not been restored to preinjury levels, and activity demands are exceeding it.
Counsel patients that ACL-reconstructed knees are rebuilt transmissions, likely with smaller envelopes than factory-new, and that incremental loading with scintigraphic or symptom-based monitoring is more rational than targeting a return-to-sport date based on laxity testing alone.
Dye's 1996 theoretical paper asks why biomechanically successful ACL reconstructions still produce degenerative knees. It proposes a conceptual framework — the knee as a biologic transmission with an envelope of function — to explain how load magnitude and frequency interact with tissue homeostasis, and why restoring normal laxity alone is insufficient to restore full joint function.
When a patient has a biomechanically well-reconstructed ACL but develops pain, effusion, or early degenerative changes, think envelope mismatch — the functional capacity of the joint has not been restored to preinjury levels, and activity demands are exceeding it.
Counsel patients that ACL-reconstructed knees are rebuilt transmissions, likely with smaller envelopes than factory-new, and that incremental loading with scintigraphic or symptom-based monitoring is more rational than targeting a return-to-sport date based on laxity testing alone.